Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.

Currey N, Jahan Z, Caldon CE, Tran PN, Benthani F, De Lacavalerie P, Roden DL, Gloss BS, Campos C, Bean EG, Bullman A, Reibe-Pal S, Dinger ME, Febbraio MA, Clarke SJ, Dahlstrom JE, Kohonen-Corish MRJ.

Cell Mol Gastroenterol Hepatol. 2019;7(4):819-839. doi: 10.1016/j.jcmgh.2019.01.009. Epub 2019 Mar 2.

2.

Microsatellite Instability in Mouse Models of Colorectal Cancer.

Currey N, Daniel JJ, Mladenova DN, Dahlstrom JE, Kohonen-Corish MRJ.

Can J Gastroenterol Hepatol. 2018 Mar 1;2018:6152928. doi: 10.1155/2018/6152928. eCollection 2018.

3.

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.

Vennin C, Chin VT, Warren SC, Lucas MC, Herrmann D, Magenau A, Melenec P, Walters SN, Del Monte-Nieto G, Conway JR, Nobis M, Allam AH, McCloy RA, Currey N, Pinese M, Boulghourjian A, Zaratzian A, Adam AA, Heu C, Nagrial AM, Chou A, Steinmann A, Drury A, Froio D, Giry-Laterriere M, Harris NL, Phan T, Jain R, Weninger W, McGhee EJ, Whan R, Johns AL, Samra JS, Chantrill L, Gill AJ, Kohonen-Corish M, Harvey RP, Biankin AV; Australian Pancreatic Cancer Genome Initiative (APGI), Evans TR, Anderson KI, Grey ST, Ormandy CJ, Gallego-Ortega D, Wang Y, Samuel MS, Sansom OJ, Burgess A, Cox TR, Morton JP, Pajic M, Timpson P.

Sci Transl Med. 2017 Apr 5;9(384). pii: eaai8504. doi: 10.1126/scitranslmed.aai8504.

4.

HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.

Mladenova DN, Dahlstrom JE, Tran PN, Benthani F, Bean EG, Ng I, Pangon L, Currey N, Kohonen-Corish MR.

Dis Model Mech. 2015 Sep;8(9):1093-103. doi: 10.1242/dmm.019000. Epub 2015 Jul 16.

5.

Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Benthani F, Tran PN, Currey N, Ng I, Giry-Laterriere M, Carey L, Kohonen-Corish MR, Pangon L.

Int J Mol Sci. 2015 May 19;16(5):11522-30. doi: 10.3390/ijms160511522.

6.

MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.

Pangon L, Mladenova D, Watkins L, Van Kralingen C, Currey N, Al-Sohaily S, Lecine P, Borg JP, Kohonen-Corish MR.

Int J Cancer. 2015 Jan 1;136(1):55-64. doi: 10.1002/ijc.28967. Epub 2014 May 27.

7.

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.

Kohonen-Corish MR, Tseung J, Chan C, Currey N, Dent OF, Clarke S, Bokey L, Chapuis PH.

Int J Cancer. 2014 Jun 15;134(12):2820-8. doi: 10.1002/ijc.28619. Epub 2013 Dec 6.

8.

Sulindac activates NF-κB signaling in colon cancer cells.

Mladenova D, Pangon L, Currey N, Ng I, Musgrove EA, Grey ST, Kohonen-Corish MR.

Cell Commun Signal. 2013 Oct 1;11:73. doi: 10.1186/1478-811X-11-73.

9.

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.

Poursoltan P, Currey N, Pangon L, van Kralingen C, Selinger CI, Mahar A, Cooper WA, Kennedy CW, McCaughan BC, Trent R, Kohonen-Corish MR.

Lung Cancer. 2012 Aug;77(2):272-6. doi: 10.1016/j.lungcan.2012.04.001. Epub 2012 Apr 26.

PMID:
22542170
10.

The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.

Mladenova D, Daniel JJ, Dahlstrom JE, Bean E, Gupta R, Pickford R, Currey N, Musgrove EA, Kohonen-Corish MR.

Gut. 2011 Mar;60(3):350-60. doi: 10.1136/gut.2010.208314. Epub 2010 Oct 27.

PMID:
20980345

Supplemental Content

Loading ...
Support Center